2232-P: Multiomics Integration Identifies Distinct Molecular Endotypes of Atypical Diabetes
Diabetes · 05.06.2026 · 75 (Supplement_1)
DOI: 10.2337/db26-2232-p ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes, erschienen am 05.06.2026. Verfasst von JORDANA FARUQI und 3 weiteren Autor:innen.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Introduction and Objective: A convergence of dysregulated metabolic, polygenic and environmental factors drives the pathophysiology of diabetes mellitus. We performed unsupervised integration of transcriptomic and metabolomic data among participants in the Rare and Atypical Diabetes Network (RADIANT) to identify distinct endotypes of atypical diabetes.
Methods
This cross-sectional, observational study included RADIANT participants meeting predefined atypical diabetes criteria (n=300). Transcriptomic and metabolomic data were integrated through NEMO (Neighborhood-Based Multi-Omics Clustering), an unsupervised multi-omics clustering algorithm. Cluster separation was evaluated using inter and intra-cluster distances, centroid signatures and Kruskal-Wallis testing with FDR correction.
Results
Integrated NEMO clustering yielded 8 subtypes with high reproducibility (mean accuracy 0.82), with 3 highly stable clusters, 3 moderately stable clusters and 2 clusters with overlapping characteristics. These endotypes reflected 3 dominant biological patterns: groups with preserved β-cell function (Clusters 1 and 4), groups indicative of increased insulin resistance with upregulated oxidative, mitochondrial, and ER-stress pathways (Clusters 2, 3, 5, and 6), and groups enriched for MYC, G2M, WNT, and Hedgehog pathways with relatively higher T1D genetic risk scores (Clusters 7 and 8). Phenotypic characteristics and dynamic testing differed among clusters, including BMI (FDR=0.019). T1D polygenic risk scores also varied across clusters (FDR=0.009). Inter- and intra-cluster distances and Prediction Analysis for Microarrays (PAMR) centroids confirmed strong separation. Together, these findings reveal distinct molecular endotypes of atypical diabetes.
Conclusion
Unsupervised integration of transcriptomic and metabolomic data identifies phenotypically and molecularly distinct endotypes. Further studies are needed to understand the underlying etiology of these endotypes and develop a more precise classification of atypical diabetes. Disclosure J. Faruqi: Research Support; Current; Rhythm Pharmaceuticals, Inc. A. Bareja: None. C. Cheng: None. A. Balasubramanyam: None. Funding The RADIANT Study is funded by U54 DK118638-07S2 and U54 DK118612 from the National Institute of Diabetes and Digestive and Kidney Diseases. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Zitieren
APA
FARUQI, J., BAREJA, A., CHENG, C., & BALASUBRAMANYAM, A. (2026). 2232-P: Multiomics Integration Identifies Distinct Molecular Endotypes of Atypical Diabetes. Diabetes, 75(Supplement_1). https://doi.org/10.2337/db26-2232-p
Vancouver
FARUQI J, BAREJA A, CHENG C, BALASUBRAMANYAM A. 2232-P: Multiomics Integration Identifies Distinct Molecular Endotypes of Atypical Diabetes. Diabetes. 2026;75(Supplement_1). doi:10.2337/db26-2232-p
BibTeX
@article{FARUQI2026,
author = {FARUQI, JORDANA and BAREJA, AKSHAY and CHENG, CHAO and BALASUBRAMANYAM, ASHOK},
title = {2232-P: Multiomics Integration Identifies Distinct Molecular Endotypes of Atypical Diabetes},
journal = {Diabetes},
year = {2026},
volume = {75},
number = {Supplement_1},
doi = {10.2337/db26-2232-p}
}
EUVIMED